[article]
| Titre : |
Autism is Not Caused by Terbutaline |
| Type de document : |
Texte imprimé et/ou numérique |
| Auteurs : |
John P. ELLIOTT, Auteur ; John C. MORRISON, Auteur |
| Article en page(s) : |
4 p. |
| Langues : |
Anglais (eng) |
| Mots-clés : |
Autism Spectrum Disorder Terbutaline pregnancy Childhood vaccinations |
| Index. décimale : |
PER Périodiques |
| Résumé : |
Objective: To identify the rate of Autism Spectrum Disorder (ASD) in children exposed to terbutaline in utero compared to patients untreated with this beta agonist. Methods: Members of three lay organizations collected data regarding significant childhood development problems following their pregnancy using a web-based survey. Results: Over a 90 day period, 11,717 surveys were sent electronically to members of the high risk pregnancy organizations. Of these, 2217 members (18.9%) responded and results showed that 965(43.5%) had received terbutaline during their pregnancies. Overall 523(23.6%) reported having at least one child with some form of chronic disability and of these 128 had a child with ASD. Of fetuses with no exposure to terabutaline 79/1252 (6.3%) had a diagnosis of ASD compared to 49/965 (5.1%) who reported a history of terbutaline exposure (p=0.233). In contrast, rematurity was strongly associated with ASD as 102/128 (80%) were delivered at <36 weeks compared to 26/128of those with ASD (20%) delivering at >36 weeks. ASD was not associated with terabutaline exposure in pregnancy; however ASD was associated with preterm delivery. |
| En ligne : |
https://dx.doi.org/10.4172/2165-7890.1000139 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=409 |
in Autism - Open Access > 5-1 [01/01/2015] . - 4 p.
[article] Autism is Not Caused by Terbutaline [Texte imprimé et/ou numérique] / John P. ELLIOTT, Auteur ; John C. MORRISON, Auteur . - 4 p. Langues : Anglais ( eng) in Autism - Open Access > 5-1 [01/01/2015] . - 4 p.
| Mots-clés : |
Autism Spectrum Disorder Terbutaline pregnancy Childhood vaccinations |
| Index. décimale : |
PER Périodiques |
| Résumé : |
Objective: To identify the rate of Autism Spectrum Disorder (ASD) in children exposed to terbutaline in utero compared to patients untreated with this beta agonist. Methods: Members of three lay organizations collected data regarding significant childhood development problems following their pregnancy using a web-based survey. Results: Over a 90 day period, 11,717 surveys were sent electronically to members of the high risk pregnancy organizations. Of these, 2217 members (18.9%) responded and results showed that 965(43.5%) had received terbutaline during their pregnancies. Overall 523(23.6%) reported having at least one child with some form of chronic disability and of these 128 had a child with ASD. Of fetuses with no exposure to terabutaline 79/1252 (6.3%) had a diagnosis of ASD compared to 49/965 (5.1%) who reported a history of terbutaline exposure (p=0.233). In contrast, rematurity was strongly associated with ASD as 102/128 (80%) were delivered at <36 weeks compared to 26/128of those with ASD (20%) delivering at >36 weeks. ASD was not associated with terabutaline exposure in pregnancy; however ASD was associated with preterm delivery. |
| En ligne : |
https://dx.doi.org/10.4172/2165-7890.1000139 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=409 |
|
Faire une suggestion Affiner la recherche
